01349 復旦張江
公司資料 - 損益表
上海復旦張江生物醫藥股份有限公司 股票編號: 01349
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO. LTD. 集團網址: http://www.fd-zj.com
2025/06 - 中期
人民幣(¥)
與去年中期比較 2024/12
人民幣(¥)
2023/12
人民幣(¥)
2022/12
人民幣(¥)
2021/12
人民幣(¥)
營業額 / 收益390,083,112-4.420%709,404,966850,733,2121,031,159,8381,140,313,088
銷售成本------------
毛利------------
 
投資物業公平值變動及減值------------
其他項目公平值變動及減值23,457,873--2,791,142(32,643,827)(525,041)497,436
出售項目溢利 / (虧損)203,05543.887%29,905295,3461,921,7671,784,690
其他非經營項目------------
分佔聯營公司及共同控制公司業績(2,131,966)-71.541%(28,553,238)(23,539,527)(20,399,820)(1,602,240)
除稅前溢利 / (虧損)5,622,200-92.212%5,457,93097,528,063132,293,548215,920,869
稅項0--33,976,14210,921,7954,978,650(3,540,164)
已終止經營業務溢利 / (虧損)------------
非控股權益92,942-27.980%299,824177,510724,900915,053
其他項目------------
股東應佔溢利 / (虧損)5,715,142-91.890%39,733,896108,627,368137,997,098213,295,758
 
淨財務支出 / (收入)(391,748)-76.629%(5,034,580)(3,703,638)(8,788,607)(4,087,716)
折舊及攤銷41,738,23811.050%82,219,82662,232,22582,189,14661,809,719
董事酬金1,746,9900.433%3,903,6704,915,6509,628,68616,287,542
 
核數師意見不適用--無保留意見無保留意見無保留意見無保留意見
 
市場價值指標
每股盈利 (仙)1.000--4.00011.00013.00021.000
每股派息 (仙)0.000--5.0007.0007.0007.000
派息比率 (%)----125.000%63.636%53.846%33.333%
每股現金流 ($)-----0.0160.0690.1600.258
每股帳面資產淨值 ($)2.199--2.2232.2742.1932.103
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.